Cybulski et al. sequenced the coding region of CHEK2 using genomic DNA from 140 Polish prostate patients and investigated a role of three variants, including CHEK2∗1100delC in prostate cancer risk. This evidence concerns the gene CHEK2 and prostate carcinoma.